» Articles » PMID: 36274865

Advances and Controversies in the Management of Osteoradionecrosis After Head and Neck Cancer Treatment: A Narrative Review

Overview
Date 2022 Oct 24
PMID 36274865
Authors
Affiliations
Soon will be listed here.
Abstract

Osteoradionecrosis (ORN) is a painful and debilitating serious late complication following treatment for head and neck cancer (HNC) often requiring surgical resection of the jaw and complex multidisciplinary management. An important aggravating factor for mandibular ORN is surgical trauma, commonly dental extractions or implant placement following head and neck radiotherapy. The evidence on the treatment protocols ranges from conservative management to more radical surgical strategies including the use of hyperbaric oxygen therapy. The available evidence on the preventive approaches for ORN includes prophylactic dental care prior to radiotherapy, the use of hyperbaric oxygen (HBO) treatment and prophylactic antibiotics for post-radiotherapy extractions. However, the efficacy of hyperbaric oxygen therapy has been questioned recently signifying poor understanding of the pathophysiology of the condition and therapies targeting the fibroatrophic process have become a focus of ORN treatment. Implementing recent IMRT radiation techniques has also shown evidence to reduce the incidence of ORN. This review provides an insight into the variations in definition and classification of the ORN, the controversies in its pathophysiology and the advances in the prevention and management.

Citing Articles

Significance of Multidisciplinary Teams for Patients with Oral and Maxillofacial Surgical Diseases: An Observational Retrospective Study in a General Hospital in China.

Chen J, Yao Q, Wang X, Jiang J, Zhu H, Yu D J Multidiscip Healthc. 2025; 17:6187-6198.

PMID: 39759085 PMC: 11697645. DOI: 10.2147/JMDH.S504720.


Diagnostic and Therapeutic Approaches to Jaw Osteoradionecrosis.

Wang Y, Turkstani H, Alfaifi A, Akintoye S Diagnostics (Basel). 2024; 14(23).

PMID: 39682583 PMC: 11640485. DOI: 10.3390/diagnostics14232676.


Oral Complications from Oropharyngeal Cancer Therapy.

Sankar V, Xu Y Cancers (Basel). 2023; 15(18).

PMID: 37760517 PMC: 10526346. DOI: 10.3390/cancers15184548.


The Progress in Reconstruction of Mandibular Defect Caused by Osteoradionecrosis.

Huang N, Wang P, Gong P, Huang B J Oncol. 2023; 2023:1440889.

PMID: 36968640 PMC: 10033216. DOI: 10.1155/2023/1440889.


Osteoradionecrosis After Mandibulotomy and Marginal Mandibulectomy in Patients With Oral Cancer.

Wongmanee S, Chotipanich A Cureus. 2023; 15(1):e33628.

PMID: 36788906 PMC: 9912006. DOI: 10.7759/cureus.33628.

References
1.
Raj R, Thankappan K, Janakiram C, Iyer S, Mathew A . Etiopathogenesis of Trismus in Patients With Head and Neck Cancer: An Exploratory Literature Review. Craniomaxillofac Trauma Reconstr. 2021; 13(3):219-225. PMC: 7797966. DOI: 10.1177/1943387520917518. View

2.
Batstone M, Cosson J, Marquart L, Acton C . Platelet rich plasma for the prevention of osteoradionecrosis. A double blinded randomized cross over controlled trial. Int J Oral Maxillofac Surg. 2011; 41(1):2-4. DOI: 10.1016/j.ijom.2011.06.018. View

3.
Caparrotti F, Huang S, Lu L, Bratman S, Ringash J, Bayley A . Osteoradionecrosis of the mandible in patients with oropharyngeal carcinoma treated with intensity-modulated radiotherapy. Cancer. 2017; 123(19):3691-3700. DOI: 10.1002/cncr.30803. View

4.
Delanian S, Lefaix J . Complete healing of severe osteoradionecrosis with treatment combining pentoxifylline, tocopherol and clodronate. Br J Radiol. 2002; 75(893):467-9. DOI: 10.1259/bjr.75.893.750467. View

5.
Wahl M . Osteoradionecrosis prevention myths. Int J Radiat Oncol Biol Phys. 2006; 64(3):661-9. DOI: 10.1016/j.ijrobp.2005.10.021. View